Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Michael F Demane. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Michael F Demane har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:NVRO / Nevro Corp. Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Michael F Demane. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Michael F Demane som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -58.266 0 -100,00
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -219.145 0 -100,00
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -164.344 0 -100,00
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -61.863 0 -100,00
2025-01-02 2024-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 7.056 61.863 12,87
2024-10-02 2024-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 4.695 54.807 9,37
2024-07-02 2024-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 3.117 50.112 6,63
2024-05-28 2024-05-23 4 NVRO NEVRO CORP
Common Stock
A - Award 19.169 46.995 68,89
2024-04-02 2024-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 1.817 33.205 5,79
2024-01-03 2023-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 1.219 31.388 4,04
2023-10-03 2023-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 1.365 30.169 4,74
2023-07-05 2023-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 1.032 28.804 3,72
2023-06-09 2023-06-07 4 NVRO NEVRO CORP
Common Stock
G - Gift -80.000 27.772 -74,23
2023-05-30 2023-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 6.754 107.772 6,69
2023-04-14 2023-04-12 4 NVRO NEVRO CORP
Common Stock
M - Exercise 80.291 101.018 387,37 18,00 1.445.238 1.818.324
2023-04-04 2023-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 726 20.727 3,63
2023-01-04 2022-12-30 4 NVRO NEVRO CORP
Common Stock
A - Award 662 20.001 3,42
2022-10-04 2022-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 563 19.339 3,00
2022-07-05 2022-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 598 44.900 1,35
2022-05-27 2022-05-26 4 NVRO NEVRO CORP
Common Stock
A - Award 4.155 44.302 10,35
2022-04-04 2022-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 362 40.147 0,91
2022-01-04 2021-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 323 44.433 0,73
2021-10-04 2021-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 225 231.660 0,10
2021-07-02 2021-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 158 231.435 0,07
2021-06-24 2021-06-22 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.445 231.277 -2,71 179,03 -1.153.837 41.405.128
2021-05-26 2021-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1.167 237.722 0,49
2021-04-02 2021-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 188 236.555 0,08
2021-01-05 2020-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 160 236.367 0,07
2020-10-13 2020-10-12 4 NVRO NEVRO CORP
Common Stock
S - Sale X -200 236.207 -0,08 151,62 -30.324 35.813.705
2020-10-13 2020-10-12 4 NVRO NEVRO CORP
Common Stock
S - Sale X -703 236.407 -0,30 151,09 -106.219 35.719.537
2020-10-13 2020-10-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -20.529 237.110 -7,97 150,31 -3.085.745 35.640.360
2020-10-02 2020-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 199 257.639 0,08
2020-09-17 2020-09-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -880 257.440 -0,34 148,19 -130.411 38.151.115
2020-09-17 2020-09-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4.169 258.320 -1,59 147,41 -614.564 38.079.649
2020-09-17 2020-09-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5.977 262.489 -2,23 146,58 -876.139 38.476.950
2020-09-17 2020-09-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5.002 268.466 -1,83 145,53 -727.928 39.069.159
2020-09-17 2020-09-15 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2.000 273.468 -0,73 145,27 -290.546 39.727.517
2020-09-04 2020-09-02 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.400 275.468 -1,22 145,25 -493.864 40.012.856
2020-08-31 2020-08-27 4 NVRO NEVRO CORP
Common Stock
S - Sale X -10.819 278.868 -3,73 141,34 -1.529.196 39.416.207
2020-08-31 2020-08-27 4 NVRO NEVRO CORP
Common Stock
S - Sale X -8.081 289.687 -2,71 140,55 -1.135.807 40.716.319
2020-08-17 2020-08-13 4 NVRO NEVRO CORP
Common Stock
S - Sale X -300 347.768 -0,09 140,05 -42.016 48.706.056
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -400 38.054 -1,04 138,70 -55.479 5.277.995
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1.000 38.454 -2,53 136,37 -136.373 5.244.087
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1.474 39.454 -3,60 135,64 -199.937 5.351.651
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1.626 40.928 -3,82 134,42 -218.563 5.501.452
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2.828 348.068 -0,81 140,11 -396.231 48.767.807
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -2.337 350.896 -0,66 138,87 -324.550 48.730.612
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.813 353.233 -1,07 138,44 -527.868 48.901.223
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -24.208 357.046 -6,35 136,18 -3.296.735 48.623.845
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -19.785 381.254 -4,93 135,58 -2.682.500 51.691.370
2020-08-12 2020-08-10 4 NVRO NEVRO CORP
Common Stock
S - Sale X -30.469 401.039 -7,06 134,34 -4.093.257 53.876.261
2020-07-02 2020-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 116 431.508 0,03
2020-05-26 2020-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 1.376 431.392 0,32
2020-04-02 2020-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 274 430.016 0,06
2020-01-03 2019-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 223 429.742 0,05
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4.610 429.519 -1,06 104,68 -482.572 44.961.791
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -37.116 434.129 -7,88 103,72 -3.849.779 45.029.119
2019-11-13 2019-11-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -8.274 471.245 -1,73 103,07 -852.812 48.571.835
2019-10-02 2019-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 305 479.519 0,06
2019-05-22 2019-05-20 4 NVRO NEVRO CORP
Common Stock
A - Award 2.913 479.214 0,61
2018-05-23 2018-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 3.785 476.301 0,80
2018-05-15 2018-05-11 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -3.631 80.291 -4,33
2018-05-15 2018-05-11 4 NVRO NEVRO CORP
Common Stock
M - Exercise 3.631 472.516 0,77 18,00 65.358 8.505.288
2017-12-22 2017-12-21 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -41.572 0 -100,00
2017-12-22 2017-12-21 4 NVRO NEVRO CORP
Common Stock
M - Exercise 41.572 468.885 9,73 3,60 149.659 1.687.986
2017-10-10 2017-10-05 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5.000 427.313 -1,16 93,50 -467.500 39.953.766
2017-09-28 2017-09-27 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5.000 432.313 -1,14 91,50 -457.500 39.556.640
2017-09-14 2017-09-13 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5.000 42.554 -10,51 89,50 -447.500 3.808.583
2017-09-13 2017-09-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4.350 47.554 -8,38 88,39 -384.494 4.203.270
2017-09-13 2017-09-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -20.650 51.904 -28,46 87,59 -1.808.705 4.546.199
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3.545 3.545
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1.518 487.313 0,31
2017-05-03 2017-05-02 4 NVRO NEVRO CORP
Common Stock
S - Sale X -16.000 485.795 -3,19 97,00 -1.552.000 47.122.115
2017-05-03 2017-05-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -13.800 501.795 -2,68 95,00 -1.311.000 47.670.525
2017-04-05 2017-04-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -300 515.595 -0,06 95,17 -28.552 49.070.878
2017-04-05 2017-04-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1.900 515.895 -0,37 94,47 -179.493 48.736.497
2017-04-05 2017-04-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -20.000 517.795 -3,72 93,26 -1.865.134 48.287.853
2017-03-30 2017-03-28 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -691 83.922 -0,82
2017-03-30 2017-03-28 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -12.929 41.572 -23,72
2017-03-30 2017-03-28 4 NVRO NEVRO CORP
Common Stock
M - Exercise 691 537.795 0,13 18,00 12.438 9.680.310
2017-03-30 2017-03-28 4 NVRO NEVRO CORP
Common Stock
M - Exercise 12.929 537.104 2,47 3,60 46.544 1.933.574
2017-02-23 2017-02-21 4 NVRO NEVRO CORP
Common Stock
S - Sale X -4.255 0 -100,00 97,30 -414.012
2017-02-23 2017-02-21 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1.745 524.175 -0,33 97,30 -169.788 51.002.228
2016-12-02 2016-11-30 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -10.000 54.501 -15,50
2016-12-02 2016-11-30 4 NVRO NEVRO CORP
Common Stock
M - Exercise 10.000 525.920 1,94 3,60 36.000 1.893.312
2016-11-10 2016-11-08 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -30.000 64.501 -31,75
2016-11-10 2016-11-08 4 NVRO NEVRO CORP
Common Stock
M - Exercise 30.000 515.920 6,17 3,60 108.000 1.857.312
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -18.750 81.250 -18,75
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -27.754 84.613 -24,70
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Common Stock
S - Sale X -27.925 485.920 -5,43 96,18 -2.685.947 46.737.875
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Common Stock
S - Sale X -18.579 513.845 -3,49 95,82 -1.780.305 49.238.426
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Common Stock
M - Exercise 18.750 532.424 3,65 63,23 1.185.562 33.665.170
2016-10-06 2016-10-06 4 NVRO NEVRO CORP
Common Stock
M - Exercise 27.754 513.674 5,71 18,00 499.572 9.246.132
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -28.918 112.367 -20,47
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -17.587 94.501 -15,69
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7.906 485.920 -1,60 98,86 -781.608 48.039.315
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Common Stock
S - Sale X -38.599 493.826 -7,25 97,86 -3.777.368 48.326.701
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Common Stock
M - Exercise 28.918 532.425 5,74 18,00 520.524 9.583.650
2016-10-06 2016-10-05 4 NVRO NEVRO CORP
Common Stock
M - Exercise 17.587 503.507 3,62 3,60 63.313 1.812.625
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
M - Exercise -46.505 112.088 -29,32
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -200 485.920 -0,04 102,29 -20.458 49.704.757
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -700 486.120 -0,14 101,45 -71.015 49.316.534
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -5.450 486.820 -1,11 100,11 -545.625 48.737.838
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -7.600 492.270 -1,52 99,00 -752.427 48.736.502
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -20.784 499.870 -3,99 97,98 -2.036.460 48.978.312
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
S - Sale X -11.771 520.654 -2,21 97,30 -1.145.371 50.661.977
2016-10-06 2016-10-04 4 NVRO NEVRO CORP
Common Stock
M - Exercise 46.505 532.425 9,57 3,60 167.418 1.916.730
2016-08-24 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.334 4.255 -43,93 99,00 -330.066 421.245
2016-08-24 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.334 4.255 -43,93 99,00 -330.066 421.245
2016-08-24 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.666 485.920 -1,35 99,00 -659.934 48.106.080
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale -3.333 1.165.460 -0,29 89,00 -296.637 103.725.940
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.334 7.589 -30,52 94,00 -313.396 713.366
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.334 7.589 -30,52 94,00 -313.396 713.366
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.333 10.923 -23,38 89,00 -296.637 972.147
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.666 492.586 -1,34 94,00 -626.604 46.303.084
2016-08-11 2016-08-09 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.667 499.252 -1,32 89,00 -593.363 44.433.428
2016-08-02 2016-07-29 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.333 14.256 -18,95 84,00 -279.972 1.197.504
2016-08-02 2016-07-29 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.333 14.256 -18,95 84,00 -279.972 1.197.504
2016-08-02 2016-07-29 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.667 505.919 -1,30 84,00 -560.028 42.497.196
2016-07-12 2016-07-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.333 17.589 -15,93 79,00 -263.307 1.389.531
2016-07-12 2016-07-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.333 17.589 -15,93 79,00 -263.307 1.389.531
2016-07-12 2016-07-11 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.667 512.586 -1,28 79,00 -526.693 40.494.294
2016-07-06 2016-07-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.333 20.922 -13,74 74,00 -246.642 1.548.228
2016-07-06 2016-07-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -3.333 20.922 -13,74 74,00 -246.642 1.548.228
2016-07-06 2016-07-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.667 519.253 -1,27 74,00 -493.358 38.424.722
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.666 24.255 -21,56 64,77 -431.783 1.571.091
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.666 24.255 -21,56 64,77 -431.783 1.571.091
2016-05-18 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -26.667 525.920 -4,83 64,77 -1.727.326 34.065.889
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -150 2.745.360 -0,01 56,22 -8.433 154.353.199
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -50 30.921 -0,16 58,99 -2.950 1.824.030
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -50 30.921 -0,16 58,99 -2.950 1.824.030
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -407 30.971 -1,30 57,75 -23.503 1.788.461
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -150 31.378 -0,48 56,22 -8.433 1.764.175
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.059 31.528 -16,12 55,01 -333.296 1.734.305
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -408 99.270 -0,41 57,75 -23.560 5.732.465
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.058 99.828 -5,72 55,01 -333.241 5.491.379
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -200 552.587 -0,04 59,06 -11.812 32.637.170
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -1.465 552.787 -0,26 57,80 -84.675 31.950.259
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -8.688 554.252 -1,54 56,80 -493.495 31.482.567
2016-03-03 2016-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -16.314 562.940 -2,82 55,10 -898.839 31.015.855
2015-12-03 2015-12-01 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 100.000 100.000
2015-11-18 2015-11-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.667 111.199 -5,66 50,52 -336.810 5.617.651
2015-11-18 2015-11-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.667 111.199 -5,66 50,52 -336.810 5.617.651
2015-11-18 2015-11-16 4 NVRO NEVRO CORP
Common Stock
S - Sale X -26.667 573.941 -4,44 50,52 -1.347.188 28.994.868
2015-09-03 2015-09-02 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.667 117.866 -5,35 45,30 -302.030 5.339.589
2015-09-03 2015-09-02 4 NVRO NEVRO CORP
Common Stock
S - Sale X -6.667 44.254 -13,09 45,30 -302.029 2.004.799
2015-09-03 2015-09-01 4 NVRO NEVRO CORP
Common Stock
S - Sale X -26.667 600.608 -4,25 45,02 -1.200.572 27.039.913
2014-11-07 2014-11-05 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 141.285 141.285
2014-11-07 2014-06-18 4 NVRO NEVRO CORP
Stock Option (right to buy)
M - Exercise -58.906 158.593 -27,08
2014-11-07 2014-06-18 4 NVRO NEVRO CORP
Common Stock
M - Exercise 58.906 617.404 10,55 3,60 212.062 2.222.654
2014-11-05 3 NVRO NEVRO CORP
Common Stock
1.420.133
2014-11-05 3 NVRO NEVRO CORP
Common Stock
936.057
2014-11-05 3 NVRO NEVRO CORP
Common Stock
854.726
2014-11-05 3 NVRO NEVRO CORP
Common Stock
1.420.133
2014-11-05 3 NVRO NEVRO CORP
Common Stock
936.057
2014-11-05 3 NVRO NEVRO CORP
Common Stock
854.726
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)